Global Infectious Disease Diagnostic Testing Industry Research Report, Growth Trends and Competitive Analysis 2022-2028
Report Code: KNJ1408755 No. of Pages: 109 Category: Pharmaceuticals and Healthcare
Publisher: Date of Publish:
Publisher: Date of Publish:
Report Overview Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Infectious Disease Diagnostic Testing estimated at US$ 17160 million in the year 2022, is projected to reach a revised size of US$ 21090 million by 2028, growing at a CAGR of 3.5% during the forecast period 2022-2028. The USA market for Infectious Disease Diagnostic Testing is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028. The China market for Infectious Disease Diagnostic Testing is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028. The Europe market for Infectious Disease Diagnostic Testing is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028. The global key companies of Infectious Disease Diagnostic Testing include Abbott, Abbott, bioMerieux, Diasorin, Roche Diagnostic, BD, Gold Standard Diagnostics, Hologic and Siemens Healthcare Diagnostics, etc. In 2021, the global top five players had a share approximately % in terms of revenue. Report Scope This latest report researches the industry structure, revenue and gross margin. Major players’ headquarters, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Infectious Disease Diagnostic Testing companies, distributors, end users, industry associations, governments' industry bureaus, industry publications, industry experts, third party database, and our in-house databases. This report also includes a discussion of the major players across each regional Infectious Disease Diagnostic Testing market. Further, it explains the major drivers and regional dynamics of the global Infectious Disease Diagnostic Testing market and current trends within the industry. Key Companies Covered In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable revenue, market share and rank data of the companies for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report: Abbott Abbott bioMerieux Diasorin Roche Diagnostic BD Gold Standard Diagnostics Hologic Siemens Healthcare Diagnostics TECHLAB Bio-Rad Laboratories Corgenix Cepheid Meridian Bioscience Market Segments This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides revenue forecast data by type and by application segments based on value for the period 2017-2028. Infectious Disease Diagnostic Testing Segment by Type Molecular Diagnostic Test POC Infectious Disease Diagnostics Test Infectious Disease Diagnostic Testing Segment by Application HIV HAIs Respiratory Tropical Diseases Liver Others Key Regions & Countries This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value data of each region and country for the period 2017-2028. North America United States Canada Europe Germany France UK Italy Russia Nordic Countries Rest of Europe Asia-Pacific China Japan South Korea Southeast Asia India Australia Rest of Asia Latin America Mexico Brazil Rest of Latin America Middle East & Africa Turkey Saudi Arabia UAE Rest of MEA Key Drivers & Barriers High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects. COVID-19 and Russia-Ukraine War Influence Analysis The readers in the section will understand how the Infectious Disease Diagnostic Testing market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Infectious Disease Diagnostic Testing Market Size Growth Rate by Type: 2017 VS 2021 VS 2028 1.2.2 Molecular Diagnostic Test 1.2.3 POC Infectious Disease Diagnostics Test 1.3 Market by Application 1.3.1 Global Infectious Disease Diagnostic Testing Market Growth Rate by Application: 2017 VS 2021 VS 2028 1.3.2 HIV 1.3.3 HAIs 1.3.4 Respiratory 1.3.5 Tropical Diseases 1.3.6 Liver 1.3.7 Others 1.4 Study Objectives 1.5 Years Considered 2 Market Perspective 2.1 Global Infectious Disease Diagnostic Testing Market Size (2017-2028) 2.2 Infectious Disease Diagnostic Testing Market Size across Key Geographies Worldwide: 2017 VS 2021 VS 2028 2.3 Global Infectious Disease Diagnostic Testing Market Size by Region (2017-2022) 2.4 Global Infectious Disease Diagnostic Testing Market Size Forecast by Region (2023-2028) 2.5 Global Top Infectious Disease Diagnostic Testing Countries Ranking by Market Size 3 Infectious Disease Diagnostic Testing Competitive by Company 3.1 Global Infectious Disease Diagnostic Testing Revenue by Players 3.1.1 Global Infectious Disease Diagnostic Testing Revenue by Players (2017-2022) 3.1.2 Global Infectious Disease Diagnostic Testing Market Share by Players (2017-2022) 3.2 Global Infectious Disease Diagnostic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Company Covered: Ranking by Infectious Disease Diagnostic Testing Revenue 3.4 Global Infectious Disease Diagnostic Testing Market Concentration Ratio 3.4.1 Global Infectious Disease Diagnostic Testing Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Infectious Disease Diagnostic Testing Revenue in 2021 3.5 Global Infectious Disease Diagnostic Testing Key Players Head office and Area Served 3.6 Key Players Infectious Disease Diagnostic Testing Product Solution and Service 3.7 Date of Enter into Infectious Disease Diagnostic Testing Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Global Infectious Disease Diagnostic Testing Breakdown Data by Type 4.1 Global Infectious Disease Diagnostic Testing Historic Revenue by Type (2017-2022) 4.2 Global Infectious Disease Diagnostic Testing Forecasted Revenue by Type (2023-2028) 5 Global Infectious Disease Diagnostic Testing Breakdown Data by Application 5.1 Global Infectious Disease Diagnostic Testing Historic Market Size by Application (2017-2022) 5.2 Global Infectious Disease Diagnostic Testing Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Infectious Disease Diagnostic Testing Revenue by Company (2020-2022) 6.2 North America Infectious Disease Diagnostic Testing Revenue by Type (2017-2028) 6.3 North America Infectious Disease Diagnostic Testing Revenue by Application (2017-2028) 6.4 North America Infectious Disease Diagnostic Testing Revenue by Country (2017-2028) 6.4.1 U.S. 6.4.2 Canada 7 Europe 7.1 Europe Infectious Disease Diagnostic Testing Revenue by Company (2020-2022) 7.2 Europe Infectious Disease Diagnostic Testing Revenue by Type (2017-2028) 7.3 Europe Infectious Disease Diagnostic Testing Revenue by Application (2017-2028) 7.4 Europe Infectious Disease Diagnostic Testing Revenue by Country (2017-2028) 7.4.1 Germany 7.4.2 France 7.4.3 U.K. 7.4.4 Italy 7.4.5 Russia 8 Asia Pacific 8.1 Asia Pacific Infectious Disease Diagnostic Testing Revenue by Company (2020-2022) 8.2 Asia Pacific Infectious Disease Diagnostic Testing Revenue by Type (2017-2028) 8.3 Asia Pacific Infectious Disease Diagnostic Testing Revenue by Application (2017-2028) 8.4 Asia Pacific Infectious Disease Diagnostic Testing Revenue by Region (2017-2028) 8.4.1 China 8.4.2 Japan 8.4.3 South Korea 8.4.4 India 8.4.5 Australia 8.4.6 Taiwan 8.4.7 Indonesia 8.4.8 Thailand 8.4.9 Malaysia 8.4.10 Philippines 8.4.11 Vietnam 9 Latin America 9.1 Latin America Infectious Disease Diagnostic Testing Revenue by Company (2020-2022) 9.2 Latin America Infectious Disease Diagnostic Testing Revenue by Type (2017-2028) 9.3 Latin America Infectious Disease Diagnostic Testing Revenue by Application (2017-2028) 9.4 Latin America Infectious Disease Diagnostic Testing Revenue by Country (2017-2028) 9.4.1 Mexico 9.4.2 Brazil 9.4.3 Argentina 10 Middle East and Africa 10.1 Middle East and Africa Infectious Disease Diagnostic Testing Revenue by Company (2020-2022) 10.2 Middle East and Africa Infectious Disease Diagnostic Testing Revenue by Type (2017-2028) 10.3 Middle East and Africa Infectious Disease Diagnostic Testing Revenue by Application (2017-2028) 10.4 Middle East and Africa Infectious Disease Diagnostic Testing Revenue by Country (2017-2028) 10.4.1 Turkey 10.4.2 Saudi Arabia 10.4.3 UAE 11 Company Profiles 11.1 Abbott 11.1.1 Abbott Company Details 11.1.2 Abbott Business Overview 11.1.3 Abbott Infectious Disease Diagnostic Testing Products and Services 11.1.4 Abbott Infectious Disease Diagnostic Testing Revenue in Infectious Disease Diagnostic Testing Business (2017-2022) 11.1.5 Abbott Infectious Disease Diagnostic Testing SWOT Analysis 11.1.6 Abbott Recent Developments 11.2 Abbott 11.2.1 Abbott Company Details 11.2.2 Abbott Business Overview 11.2.3 Abbott Infectious Disease Diagnostic Testing Products and Services 11.2.4 Abbott Infectious Disease Diagnostic Testing Revenue in Infectious Disease Diagnostic Testing Business (2017-2022) 11.2.5 Abbott Infectious Disease Diagnostic Testing SWOT Analysis 11.2.6 Abbott Recent Developments 11.3 bioMerieux 11.3.1 bioMerieux Company Details 11.3.2 bioMerieux Business Overview 11.3.3 bioMerieux Infectious Disease Diagnostic Testing Products and Services 11.3.4 bioMerieux Infectious Disease Diagnostic Testing Revenue in Infectious Disease Diagnostic Testing Business (2017-2022) 11.3.5 bioMerieux Infectious Disease Diagnostic Testing SWOT Analysis 11.3.6 bioMerieux Recent Developments 11.4 Diasorin 11.4.1 Diasorin Company Details 11.4.2 Diasorin Business Overview 11.4.3 Diasorin Infectious Disease Diagnostic Testing Products and Services 11.4.4 Diasorin Infectious Disease Diagnostic Testing Revenue in Infectious Disease Diagnostic Testing Business (2017-2022) 11.4.5 Diasorin Infectious Disease Diagnostic Testing SWOT Analysis 11.4.6 Diasorin Recent Developments 11.5 Roche Diagnostic 11.5.1 Roche Diagnostic Company Details 11.5.2 Roche Diagnostic Business Overview 11.5.3 Roche Diagnostic Infectious Disease Diagnostic Testing Products and Services 11.5.4 Roche Diagnostic Infectious Disease Diagnostic Testing Revenue in Infectious Disease Diagnostic Testing Business (2017-2022) 11.5.5 Roche Diagnostic Infectious Disease Diagnostic Testing SWOT Analysis 11.5.6 Roche Diagnostic Recent Developments 11.6 BD 11.6.1 BD Company Details 11.6.2 BD Business Overview 11.6.3 BD Infectious Disease Diagnostic Testing Products and Services 11.6.4 BD Infectious Disease Diagnostic Testing Revenue in Infectious Disease Diagnostic Testing Business (2017-2022) 11.6.5 BD Infectious Disease Diagnostic Testing SWOT Analysis 11.6.6 BD Recent Developments 11.7 Gold Standard Diagnostics 11.7.1 Gold Standard Diagnostics Company Details 11.7.2 Gold Standard Diagnostics Business Overview 11.7.3 Gold Standard Diagnostics Infectious Disease Diagnostic Testing Products and Services 11.7.4 Gold Standard Diagnostics Infectious Disease Diagnostic Testing Revenue in Infectious Disease Diagnostic Testing Business (2017-2022) 11.7.5 Gold Standard Diagnostics Infectious Disease Diagnostic Testing SWOT Analysis 11.7.6 Gold Standard Diagnostics Recent Developments 11.8 Hologic 11.8.1 Hologic Company Details 11.8.2 Hologic Business Overview 11.8.3 Hologic Infectious Disease Diagnostic Testing Products and Services 11.8.4 Hologic Infectious Disease Diagnostic Testing Revenue in Infectious Disease Diagnostic Testing Business (2017-2022) 11.8.5 Hologic Infectious Disease Diagnostic Testing SWOT Analysis 11.8.6 Hologic Recent Developments 11.9 Siemens Healthcare Diagnostics 11.9.1 Siemens Healthcare Diagnostics Company Details 11.9.2 Siemens Healthcare Diagnostics Business Overview 11.9.3 Siemens Healthcare Diagnostics Infectious Disease Diagnostic Testing Products and Services 11.9.4 Siemens Healthcare Diagnostics Infectious Disease Diagnostic Testing Revenue in Infectious Disease Diagnostic Testing Business (2017-2022) 11.9.5 Siemens Healthcare Diagnostics Infectious Disease Diagnostic Testing SWOT Analysis 11.9.6 Siemens Healthcare Diagnostics Recent Developments 11.10 TECHLAB 11.10.1 TECHLAB Company Details 11.10.2 TECHLAB Business Overview 11.10.3 TECHLAB Infectious Disease Diagnostic Testing Products and Services 11.10.4 TECHLAB Infectious Disease Diagnostic Testing Revenue in Infectious Disease Diagnostic Testing Business (2017-2022) 11.10.5 TECHLAB Infectious Disease Diagnostic Testing SWOT Analysis 11.10.6 TECHLAB Recent Developments 11.11 Bio-Rad Laboratories 11.11.1 Bio-Rad Laboratories Company Details 11.11.2 Bio-Rad Laboratories Business Overview 11.11.3 Bio-Rad Laboratories Infectious Disease Diagnostic Testing Products and Services 11.11.4 Bio-Rad Laboratories Infectious Disease Diagnostic Testing Revenue in Infectious Disease Diagnostic Testing Business (2017-2022) 11.11.5 Bio-Rad Laboratories Recent Developments 11.12 Corgenix 11.12.1 Corgenix Company Details 11.12.2 Corgenix Business Overview 11.12.3 Corgenix Infectious Disease Diagnostic Testing Products and Services 11.12.4 Corgenix Infectious Disease Diagnostic Testing Revenue in Infectious Disease Diagnostic Testing Business (2017-2022) 11.12.5 Corgenix Recent Developments 11.13 Cepheid 11.13.1 Cepheid Company Details 11.13.2 Cepheid Business Overview 11.13.3 Cepheid Infectious Disease Diagnostic Testing Products and Services 11.13.4 Cepheid Infectious Disease Diagnostic Testing Revenue in Infectious Disease Diagnostic Testing Business (2017-2022) 11.13.5 Cepheid Recent Developments 11.14 Meridian Bioscience 11.14.1 Meridian Bioscience Company Details 11.14.2 Meridian Bioscience Business Overview 11.14.3 Meridian Bioscience Infectious Disease Diagnostic Testing Products and Services 11.14.4 Meridian Bioscience Infectious Disease Diagnostic Testing Revenue in Infectious Disease Diagnostic Testing Business (2017-2022) 11.14.5 Meridian Bioscience Recent Developments 12 Infectious Disease Diagnostic Testing Market Dynamics 12.1 Infectious Disease Diagnostic Testing Market Trends 12.2 Infectious Disease Diagnostic Testing Market Drivers 12.3 Infectious Disease Diagnostic Testing Market Challenges 12.4 Infectious Disease Diagnostic Testing Market Restraints 13 Research Findings and Conclusion 14 Appendix 14.1 Research Methodology 14.1.1 Methodology/Research Approach 14.1.2 Data Source 14.2 Author Details
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com